COR logo

Cencora (COR) Company Overview

Profile

Full Name:

Cencora, Inc.

Sector:

Healthcare

Industry:

Medical Distribution

Country:

United States

IPO:

April 4, 1995

Indexes:

S&P 500

Website:

http://www.cencora.com

Description:

CoreSite Realty Corporation is an American REIT company that owns data centers predominantly in North America. Founded in 2010, in Maryland, the headquarters is located in the city of Denver, Colorado. The company owns 23 data centers in the United States. Data centers are highly specialized and secure buildings that house network infrastructure, storage, and communication technologies, including servers, storage devices, switches, routers, and equipment for fiber optic transmission. The company's data centers are located in major cities, in close proximity to client facilities, in the San Francisco Bay Area, Los Angeles, Northern Virginia (including Washington, D.C.), New York, Boston, Chicago, Denver, and Miami.

Key Details

Price

$254.58

Market Cap

$11.25 B(Large cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$293.96 B(+12.12% YoY)

Annual EPS

$7.53(-11.72% YoY)

PE Ratio

36.32

Annual ROE

233.63%

Annual Debt To Equity

6.79

Beta

0.11

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 13, 2014

Analyst ratings

Recent major analysts updates

Feb 6, 25 Evercore ISI Group
Outperform
Jan 29, 25 Wells Fargo
Equal-Weight
Jan 24, 25 JP Morgan
Overweight
Dec 13, 24 Wells Fargo
Equal-Weight
Nov 7, 24 UBS
Buy
Nov 7, 24 Evercore ISI Group
Outperform
Nov 7, 24 Barclays
Overweight
Nov 7, 24 Baird
Outperform
Aug 21, 24 JP Morgan
Overweight
Aug 1, 24 Wells Fargo
Equal-Weight

Screeners with COR included

US stocks
S&P 500 companies earnings calendar
Most recommended stocks
Best performing stocks last 3 months
Best performing stocks last 5 years
Stocks above SMA 50
S&P 500 companies
Stocks below analysts price target
S&P 500 companies dividend calendar
Healthcare sector

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$254.58
COR price is $254.58

Price All-time High

$258.11
COR price is currently -1.37% below its historical high of $258.11

Price Analysts Target

$280.00
COR price is currently -9.08% lower than the consensus analysts' forecast

Price Most Recent Change

-0.51%
COR price was down -0.51% on Mar 7, 2025

Price YTD Change

+11.79%
COR price is up +11.79% since January 1st

Price 3-Year Change

+75.77%
COR price is up +75.77% over the past 3 years

Market cap

Market Cap

$11.25 B
COR market capitalization is $11.25 billion

Market Cap 3-Year Change

+75.77%
COR market capitalization is up +75.77% over the past 3 years

Market Cap All-time High

$11.41 B
COR market capitalization is currently -1.37% below its historical high of $11.41 billion

Market Cap Sector Rank

92.92%
COR market capitalization is higher than 92.92% of companies in Healthcare sector

Technical

Beta

0.11
COR beta is 0.11

200-day SMA

$235.73
COR price is currently +8.00% above its 200-day simple moving average

14-day RSI

60.37
COR 14-day relative strength index is 60.37

30-day Relative Volume

1.13
COR 30-day relative volume is 1.13

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$293.96 B
COR annual revenue is $293.96 billion

Annual Revenue Analysts Estimate

$322.93 B
COR annual revenue is currently -8.97% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+12.12%
COR annual revenue is up +12.12% year-on-year

Annual Revenue Sector Rank

99.66%
COR annual revenue is higher than 99.66% of companies in Healthcare sector

Profit

Annual Gross Profit

$9.91 B
COR annual gross profit is $9.91 billion

Annual Gross Margin

3.37%
COR annual gross profit margin is 3.37%

Annual Operating Profit

$3.16 B
COR annual operating income is $3.16 billion

Annual Operating Margin

1.07%
COR annual operating profit margin is 1.07%

Annual Net Income

$1.51 B
COR annual net profit is $1.51 billion

Annual Net Margin

-
COR annual net profit margin value is unknown

EPS

Annual EPS

$7.53
COR annual earnings per share is $7.53

Annual EPS Analysts Estimate

$15.38
COR annual earnings per share is currently -51.03% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-11.72%
COR annual earnings per share is down -11.72% year-on-year

Annual EPS Sector Rank

97.37%
COR annual earnings per share is higher than 97.37% of companies in Healthcare sector

ROA & ROE

Annual ROA

2.25%
COR annual return on assets is 2.25%

Annual ROE

233.63%
COR annual return on equity is 233.63%

EBIT & EBITDA

Annual EBIT

$2.25 B
COR annual earnings before interest & taxes is $2.25 billion

Annual EBITDA

$4.35 B
COR annual EBITDA is $4.35 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

36.32
COR price to earnings ratio is 36.32

PE Ratio Sector Rank

67.49%
COR price to earnings ratio is higher than 67.49% of companies in Healthcare sector

PB Ratio

PB Ratio

-0.89
COR price to book ratio is -0.89

PB Ratio Sector Rank

9.56%
COR price to book ratio is higher than 9.56% of companies in Healthcare sector

PS Ratio

PS Ratio

0.04
COR price to sales ratio is 0.04

PS Ratio Sector Rank

3.39%
COR price to sales ratio is higher than 3.39% of companies in Healthcare sector

Enterprise value

Enterprise Value

$16.18 B
COR enterprise value is $16.18 billion

Enterprise Value Sector Rank

94.02%
COR enterprise value is higher than 94.02% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

3.74
COR EV/EBITDA is 3.74

EV/EBITDA Sector Rank

77.93%
COR EV/EBITDA is higher than 77.93% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.88
COR annual current ratio is 0.88

Annual Quick Ratio

0.53
COR annual quick ratio is 0.53

Leverage

Annual Debt To Equity

6.79
COR annual debt to equity ratio is 6.79

Annual Interest Coverage Ratio

9.06
COR annual interest coverage ratio is 9.06

Risk & Stability

Piotroski F-Score

5
COR piotroski f-score is 5

Altman Z-Score

4.59
COR altman z-score is 4.59

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$67.10 B
COR annual total assets is $67.10 billion

Annual Non Current Assets

$19.38 B
COR annual long term assets is $19.38 billion

Annual Current Assets

$47.72 B
COR annual total current assets is $47.72 billion

Annual Cash & Cash Equivalents

$3.13 B
COR annual cash & cash equivalents is $3.13 billion

Equity

Annual Book Value

-$12.67 B
COR annual book value is -$12.67 billion

Annual Working Capital

-$6.56 B
COR annual working capital is -$6.56 billion

Liabilities

Annual Total Liabilities

$66.31 B
COR annual total liabilities is $66.31 billion

Annual Total Long Term Liabilities

$12.04 B
COR annual total long term liabilities is $12.04 billion

Annual Current Liabilities

$54.28 B
COR annual total current liabilities is $54.28 billion

Annual Accounts Payable

$50.94 B
COR annual accounts payable is $50.94 billion

Debt

Annual Total Debt

$4.39 B
COR annual total debt is $4.39 billion

Annual Total Debt 1-Year Change

-8.34%
COR annual total debt is down -8.34% year-on-year

Annual Long Term Debt

$3.81 B
COR annual long term debt is $3.81 billion

Annual Short Term Debt

$576.33 M
COR annual short term debt is $576.33 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$290.80 B
COR annual total expenses is $290.80 billion

Annual Operating Expenses

$6.75 B
COR annual total operating expenses is $6.75 billion

Annual Cost Of Goods Sold

$284.05 B
COR annual cost of goods sold is $284.05 billion

Annual SGA

$5.66 B
COR annual SGA is $5.66 billion

Annual D&A

$1.12 B
COR annual depreciation & amortization is $1.12 billion

Annual Interest Expense

$248.68 M
COR annual interest expense is $248.68 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$3.48 B
COR annual cash flow from operations is $3.48 billion

Annual CFO 1-Year Change

-10.91%
COR annual cash flow from operations is down -10.91% year-on-year

Annual CFI

-$618.10 M
COR annual cash flow from investing activities is -$618.10 million

Annual CFI 1-Year Change

+76.25%
COR annual cash flow from investing activities is up +76.25% year-on-year

Annual CFF

-$2.33 B
COR annual cash flow from financing activities is -$2.33 billion

Annual CFF 1-Year Change

-4.89%
COR annual cash flow from financing activities is down -4.89% year-on-year

Free CashFlow

Annual FCF

$3.00 B
COR annual free cash flow is $3.00 billion

Annual FCF 1-Year Change

-13.19%
COR annual free cash flow is down -13.19% year-on-year

CAPEX

Annual CAPEX

$487.17 M
COR annual capital expenditures is $487.17 million

Annual CAPEX 1-Year Change

+6.29%
COR annual capital expenditures is up +6.29% year-on-year

Institutional Ownership

Similar stocks

NBIX logo
Neurocrine Biosciences (NBIX)
UHS logo
Universal Health Services (UHS)
DVA logo
DaVita (DVA)
VTRS logo
Viatris (VTRS)
EXEL logo
Exelixis (EXEL)
RDY logo
Dr Reddys Laboratories Limited (RDY)
PEN logo
Penumbra (PEN)
AVTR logo
Avantor (AVTR)
DOCS logo
Doximity (DOCS)

FAQ

  • What is the ticker symbol for Cencora?
  • Does Cencora pay dividends?
  • What sector is Cencora in?
  • What industry is Cencora in?
  • What country is Cencora based in?
  • When did Cencora go public?
  • Is Cencora in the S&P 500?
  • Is Cencora in the NASDAQ 100?
  • Is Cencora in the Dow Jones?
  • When does Cencora report earnings?
  • Should I buy Cencora stock now?

What is the ticker symbol for Cencora?

The ticker symbol for Cencora is NYSE:COR

Does Cencora pay dividends?

No, Cencora does not pay dividends

What sector is Cencora in?

Cencora is in the Healthcare sector

What industry is Cencora in?

Cencora is in the Medical Distribution industry

What country is Cencora based in?

Cencora is headquartered in United States

When did Cencora go public?

Cencora's initial public offering (IPO) was on April 4, 1995

Is Cencora in the S&P 500?

Yes, Cencora is included in the S&P 500 index

Is Cencora in the NASDAQ 100?

No, Cencora is not included in the NASDAQ 100 index

Is Cencora in the Dow Jones?

No, Cencora is not included in the Dow Jones index

When does Cencora report earnings?

The date for Cencora's next earnings report has not been announced yet

Should I buy Cencora stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions